Collegium Pharmaceutical ...
33.15
-0.64 (-1.89%)
At close: Jan 14, 2025, 3:59 PM
33.18
0.09%
After-hours Jan 14, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Revenue 566.77M 463.93M 276.87M 310.02M 296.70M 280.41M 28.48M 1.71M n/a n/a n/a
Cost of Revenue 240.60M 254.44M 126.25M 130.18M 193.66M 165.68M 2.60M 213.00K 171.00K n/a n/a
Gross Profit 326.17M 209.49M 150.62M 179.84M 103.04M 114.74M 25.88M 1.50M -171.00K n/a n/a
Operating Income 166.96M -104.57M -46.70M -5.09M -23.75M -20.68M -75.45M -94.08M -26.91M -17.66M -16.04M
Interest Income 15.62M 1.05M 12.00K 232.00K 1.94M 1.69M 582.00K n/a n/a n/a n/a
Pretax Income 75.73M -28.85M -3.37M 27.58M -22.72M -39.13M -74.86M -94.18M -27.25M -17.92M -16.20M
Net Income 48.16M -25.00M 71.52M 26.75M -8.15M -39.13M -74.86M -94.18M -27.25M -17.92M -16.20M
Selling & General & Admin 159.21M 172.19M 118.96M 113.83M 116.45M 126.76M 92.76M 80.63M 18.93M 2.71M 1.89M
Research & Development n/a 3.98M 9.45M 9.77M 10.34M 8.66M 8.57M 14.95M 7.97M 14.96M 14.16M
Other Expenses n/a n/a n/a n/a n/a n/a n/a -94.00K -348.00K n/a n/a
Operating Expenses 150.71M 176.17M 128.41M 123.60M 126.79M 135.42M 101.33M 95.58M 26.91M 17.66M 16.04M
Interest Expense 83.34M 63.21M 21.01M 28.88M 909.00K 20.13M 582.00K 94.00K 439.00K 252.00K 76.00K
Selling & Marketing Expenses 7.41M 11.74M 4.19M 5.37M 116.45M 126.76M 92.76M 80.63M n/a n/a n/a
Cost & Expenses 399.81M 430.61M 254.66M 253.78M 320.45M 301.10M 103.92M 95.79M 26.91M 17.66M 16.04M
Income Tax 27.58M -3.85M -74.89M 830.00K -14.57M -110.91M -1.16M 94.00K -91.00K 252.00K 79.00K
Shares Outstanding (Basic) 33.74M 33.83M 34.94M 34.41M 33.45M 32.88M 30.27M 24.26M 13.54M 7.47M 7.47M
Shares Outstanding (Diluted) 41.79M 33.83M 41.05M 35.15M 33.45M 32.95M 30.27M 24.26M 13.54M 7.47M 7.47M
EPS (Basic) 1.60 -0.74 2.05 0.78 -0.24 -1.19 -2.47 -3.88 -2.01 -2.4 -2.17
EPS (Diluted) 1.29 -0.74 1.86 0.76 -0.24 -1.19 -2.47 -3.88 -2.01 -2.4 -2.17
EBITDA 308.33M 168.76M 86.58M 118.07M -6.02M 91.91M -74.27M -93.43M -26.64M -17.48M -15.95M
Depreciation & Amortization 149.26M 134.39M 68.94M 61.61M 15.80M 110.91M 594.00K 655.00K 171.00K 187.00K 169.00K